SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : IMMULOGIC

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Paul Getman who wrote (12)3/25/1996 12:28:00 PM
From: Bhag Karamchandani   of 305
 
Paul: Thanks for taking the time to outline your well thought out assessment of IMUL. The stock price seems to have stablized- reinforcing your views. I guess the next milestone is in June - when Allervax Phase III results will be announced.

The absence of a marketing and distribution partner would adversely affect the introduction of Allervax - don't you think? And what about the need to find partners to fund the research towards availability of the drug in oral rather than injection form ? Can they do it on thier own? Any comments. Thanks.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext